The Inherited Neuropathies

Neurologic Clinics

Volumn 25, Issue 1, 2007, Pages 173-207

  Klein, Christopher J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; AMINO ACID TRANSFER RNA LIGASE; ATAXIN 1; CONNEXIN 32; DYNAMIN II; EARLY GROWTH RESPONSE FACTOR; GANGLIOSIDE; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK PROTEIN; KINESIN; MYELIN; TYROSINE TRANSFER RNA LIGASE;

ACTIN FILAMENT; APOPTOSIS; AUTOSOMAL DOMINANT INHERITANCE; BASEMENT MEMBRANE; DNA REPLICATION; FUNCTIONAL ASSESSMENT; GAP JUNCTION; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENETIC PREDISPOSITION; HEREDITARY MOTOR SENSORY NEUROPATHY; HOMEOSTASIS; HUMAN; HUMAN GENOME; MOLECULAR BIOLOGY; NERVE FIBER TRANSPORT; NEUROPATHY; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SPINOCEREBELLAR DEGENERATION;

DEMYELINATING DISEASES; DNA MUTATIONAL ANALYSIS; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MOLECULAR BIOLOGY; NERVE TISSUE PROTEINS; PHENOTYPE; POINT MUTATION; SPINOCEREBELLAR ATAXIAS;

EID: 33847102667     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2006.12.001     Document Type: Review

References (178)

1. New GENE TESTS. Available at: http://www.geneclinics.org/. Accessed Winter 2006.
2. New OMIM. Available at: http://www.ncbi.nlm.nih.gov/. Accessed Winter 2006.
3. New IPNMDB. Available at: http://www.molgen.ua.ac.be/cmt/. Accessed Winter 2006.
4. Dyck P.J., Oviatt K.F., and Lambert E.H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 10 (1981) 222-226
5. Kleopa K.A., and Scherer S.S. Inherited neuropathies. Neurol Clin 20 (2002) 679-709
6. Scherer S.S. Finding the causes of inherited neuropathies. Arch Neurol 63 (2006) 812-816
7. Michael E., Shy J.R.L., Phillip F., et al. Hereditary motor and sensory neuropathies: an overview of clinical, genetic, electrophysiologic, and pathologic features. In: Dyck P.J., and Thomas P.K. (Eds). Peripheral neuropathy. 4th ed. (2005), Elsevier Saunders, Philadelphia 1623-1658
8. Klein C.J., and Dyck P.J. HMSNII (CMT2) and miscellaneous inherited system atrophies of nerve axon: clinical-molectular correlates. In: Dyck P.J., and Thomas P.K. (Eds). Peripheral neuropathy. 4th ed. (2005), Elsevier Saunders, Philadelphia 1717-1751
9. Dyck P.J., et al. Histologic and lipid studies of sural nerves in inherited hypertrophic neuropathy: preliminary report of a lipid abnormality in nerve and liver in Dejerine-Sottas disease. Mayo Clin Proc 45 (1970) 286-327
10. Dyck P.J., Karnes J.L., and Lambert E.H. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 39 (1989) 1302-1308
11. Collins MPK. Neuropathies with systemic vasculitis. In: Dyck PJ, Thomas, PK, editors. Peripheral neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 2335-404.
12. Dyck PJE J, Dyck PJ. Microvasculitis. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005. p. 2405-14.
13. Susuki K., et al. Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons. Ann Neurol 54 (2003) 383-388
14. Griffin J.W., et al. Guillain-Barre syndrome in Northern China. The spectrum of neuropathological changes in clinical defined cases. Brain 118 (1995) 577-595
15. McKhann G.M., et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33 (1993) 333-342
16. Umapathi T., and Chaudhry V. Toxic neuropathy. Curr Opin Neurol 18 (2005) 574-580
17. Virchow E. Ein Fall von progressiven Muskelatrophie. Arch Pathol Anat 8 (1855) 537
18. Eichorst U. Ueber Heredtat de Progresiven Muskelatrophie. Berl Klin Wochenschr 10 497 (1873)
19. Charcot J.M. P, Sur une forme particuliere d'atrophie musculaire progressive souvent familial debutant par les pieds et les jambes et atteignant plus tard les mains. Rev Med (Paris) 6 (1886) 97
20. Tooth H. The peroneal type of progressive muscular atrophy (1886), Lewis, London
21. Davidenkow S. Uber die neurotische Muskelatrophie Charcot Marie: Klinisch-genetische Studien. Z Neurol 107 (1927) 259
22. Dyck P.J., and Lambert E.H. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18 (1968) 619-625
23. D'Urso D., and Muller H.W. Ins and outs of peripheral myelin protein-22: mapping transmembrane topology and intracellular sorting. J Neurosci Res 49 (1997) 551-562
24. Naef R.S. U, Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microscop Res Techniques 41 (1998) 359-371
25. Hanemann C.O., and Muller H.W. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy. Trends Neurosci 21 (1998) 282-286
26. Windebank A. Inherited recurrent focal neuropathies. In: Dyck P.J., Low P.A., and Poduslo J.F. (Eds). Peripheral neuropathy (1993), Saunders, Philadelphia 1137-1160
27. Gabreels-Festen A.A., et al. The status of HMSN type III. Neuromuscul Disord 4 (1994) 63-69
28. Dejerine H., and Sottas J. Sur la nevritte interstitielle hypertropphique et progressive de L'enfance. CR Soc Biol (Paris) 45 (1893) 63
29. Ionasescu V.V., Ionasescu R., and Searby C. Screening of dominantly inherited Charcot-Marie-Tooth neuropathies. Muscle Nerve 16 (1993) 1232-1238
30. Wise C.A., et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 53 (1993) 853-863
31. Chance P.F., et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72 (1993) 143-151
32. Pentao L., et al. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 2 (1992) 292-300
33. Lopes J., et al. Sex-dependent rearrangements resulting in CMT1A and HNPP. Nat Genet 17 (1997) 136-137
34. Bissar-Tadmouri N., et al. Mutational analysis and genotype/phenotype correlation in Turkish Charcot-Marie-Tooth Type 1 and HNPP patients. Clin Genet 58 (2000) 396-402
35. Nicholson G.A., et al. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 6 (1994) 263-266
36. Gabreels-Festen A.A., et al. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol (Berl) 90 (1995) 645-649
37. Roa B.B., et al. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 329 (1993) 96-101
38. Valentijn L.J., et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot- Marie-Tooth disease type 1A. Nat Genet 2 (1992) 288-291
39. Marrosu M.G., et al. A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marie-Tooth disease type 1A. Neurology 48 (1997) 489-493
40. Roa B.B., et al. Evidence for a recessive PMP 22 point mutation in Charcot-Marie-Tooth disease type 1A. Nat Genet (1993)
41. Numakura C., et al. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1. Ann Neurol 47 (2000) 101-103
42. Parman Y., et al. Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease. Ann Neurol 45 (1999) 518-522
43. Roa B.B., et al. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 5 (1993) 269-273
44. Ionasescu V.V., et al. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45 (1995) 1766-1767
45. Ionasescu V.V., Searby C., and Greenberg S.A. Dejerine-Sottas disease with sensorineural hearing loss, nystagmus, and peripheral facial nerve weakness: de novo dominant point mutation of the PMP22 gene. J Med Genet 33 (1996) 1048-1049
46. Ionasescu V.V., et al. Dejerine-Sottas neuropathy in mother and son with same point mutation of PMP22 gene. Muscle Nerve 20 (1997) 97-99
47. Dyck J., and Lambert E.H. Lower motor and primary sensory neruon diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18 (1968) 603, 619
48. Yoshikawa H., et al. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 35 (1994) 445-450
49. Schenone A., et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 48 (1997) 445-449
50. Lupski J.R., et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66 (1991) 219-232
51. LeGuern E., et al. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease. Ann Neurol 41 (1997) 104-108
52. Sahenk Z., et al. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology 65 (2005) 681-689
53. Sereda M.W., et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 9 (2003) 1533-1537
54. Passage E., et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 10 (2004) 396-401
55. Greenfield S., et al. Protein composition of myelin of the peripheral nervous system. J Neurochem 20 (1973) 1207-1216
56. Shapiro L., et al. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17 (1996) 435-449
57. Lai C., et al. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc Natl Acad Sci U S A 84 (1987) 4337-4341
58. Lemke G., and Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40 (1985) 501-508
59. Yan W.X., et al. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50 (2001) 286-292
60. Donaghy M., et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 69 (2000) 799-805
61. Shy M.E. Hereditary motor and sensory neuropathies related to MPZ (Po) muations. In: Dyck P.J., and Thomas P.K. (Eds). Peripheral neuropathy. 4th edition (2005), Elsevier Saunders, Philadelphia 1681-1706
62. Burns T.M., et al. Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy. Neuromuscul Disord 16 (2006) 308-310
63. Kilfoyle D.H., et al. Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis. J Neurol Neurosurg Psychiatry 77 (2006) 963-966
64. Almsaddi M., Bertorini T.E., and Seltzer W.K. Demyelinating neuropathy in a patient with multiple sclerosis and genotypical HMSN-1. Neuromuscul Disord 8 (1998) 87-89
65. Maurer M., et al. Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants. Mol Cell Neurosci 17 (2001) 1094-1101
66. Street V.A., et al. Mapping of Charcot-Marie-Tooth disease type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies. Am J Hum Genet 70 (2002) 244-250
67. Street V.A., et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 60 (2003) 22-26
68. Saifi G.M., et al. SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Hum Mutat 25 (2005) 372-383
69. Chung K.W., et al. Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot-Marie-Tooth disease family. Neurogenetics 6 (2005) 159-163
70. Boerkoel C.F., et al. EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics 3 (2001) 153-157
71. Warner L.E., et al. Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet 8 (1999) 1245-1251
72. Warner L.E., et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 18 (1998) 382-384
73. Joseph L.J., et al. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci U S A 85 (1988) 7164-7168
74. Zorick T.S., et al. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8 (1996) 129-145
75. Topilko P., et al. Krox-20 controls myelination in the peripheral nervous system. Nature 371 (1994) 796-799
76. Jordanova A., et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 126 Pt 3 (2003) 590-597
77. Georgiou D.M., et al. A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4 (2002) 93-96
78. Mersiyanova I.V., et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67 (2000) 37-46
79. De Jonghe P., et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 49 (2001) 245-249
80. Yamamoto M., et al. Glu528del in NEFL is a polymorphic variant rather than a disease-causing mutation for Charcot-Marie-Tooth disease in Japan. Neurogenetics 5 (2004) 75-77
81. Brownlees J., et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum Mol Genet 11 (2002) 2837-2844
82. Rozental R., Giaume C., and Spray D.C. Gap junctions in the nervous system. Brain Res Brain Res Rev 32 (2000) 11-15
83. Ressot C., and Bruzzone R. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res Brain Res Rev 32 (2000) 192-202
84. Ionasescu V.V., et al. X-linked recessive Charcot-Marie-Tooth neuropathy: clinical and genetic study. Muscle Nerve 15 (1992) 368-373
85. Nicholson G.A., Yeung L., and Corbett A. Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth families: ten novel mutations. Neurology 51 (1998) 1412-1416
86. Birouk N., et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology 50 (1998) 1074-1082
87. Lewis R.A., and Shy M.E. Electrodiagnostic findings in CMTX: a disorder of the Schwann cell and peripheral nerve myelin. Ann N Y Acad Sci 883 (1999) 504-507
88. Hahn A.F., et al. Genotype/phenotype correlations in X-linked dominant Charcot-Marie- Tooth disease. Ann N Y Acad Sci 883 (1999) 366-382
89. Tabaraud F., et al. Demyelinating X-linked Charcot-Marie-Tooth disease: unusual electrophysiological findings. Muscle Nerve 22 (1999) 1442-1447
90. Gutierrez A., et al. Unusual electrophysiological findings in X-linked dominant Charcot- Marie-Tooth disease. Muscle Nerve 23 (2000) 182-188
91. Panas M., et al. Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene. Neurology 57 (2001) 1906-1908
92. Marques Jr. W., et al. Central nervous system involvement in a novel connexin 32 mutation affecting identical twins. J Neurol Neurosurg Psychiatry 66 (1999) 803-804
93. Sahenk Z., and Chen L. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. J Neurosci Res 51 (1998) 174-184
94. Ionasescu V., Ionasescu R., and Searby C. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 63 (1996) 486-491
95. Nelis E., Haites N., and Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 13 (1999) 11-28
96. Nakagawa M., et al. Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 185 (2001) 31-37
97. Abrams C.K., et al. Mutations in connexin 32: the molecular and biophysical bases for the X- linked form of Charcot-Marie-Tooth disease. Brain Res Brain Res Rev 32 (2000) 203-214
98. Cuesta A.P., Sevilla L., Garcia-Planells T., et al. The gene encoding ganglioside-induced differentiation-associate protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat Genet 30 (2002) 22-24
99. Claramunt R., et al. Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J Med Genet 42 (2005) 358-365
100. Birouk N., et al. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch Neurol 60 (2003) 598-604
101. Baxter R.V., et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat Genet 30 (2002) 21-22
102. Nelis E., et al. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 59 (2002) 1865-1872
103. Boerkoel C.F., et al. CMT4A: identification of a Hispanic GDAP1 founder mutation. Ann Neurol 53 (2003) 400-405
104. Berger P., et al. Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 11 (2002) 1569-1579
105. Bolino A., et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25 (2000) 17-19
106. Bolino A., et al. Molecular characterization and expression analysis of Mtmr2, mouse homologue of MTMR2, the Myotubularin-related 2 gene, mutated in CMT4B. Gene 283 (2002) 17-26
107. Kalaydjieva L., et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67 (2000) 47-58
108. Morar B., et al. Mutation history of the roma/gypsies. Am J Hum Genet 75 (2004) 596-609
109. Hunter M., et al. Mutation screening of the N-myc downstream-regulated gene 1 (NDRG1) in patients with Charcot-Marie-Tooth Disease. Hum Mutat 22 (2003) 129-135
110. Scherer S.S., and Arroyo E.J. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7 (2002) 1-12
111. Dytrych L., et al. Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J Biol Chem 273 (1998) 5794-5800
112. Scherer S.S., et al. Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 121 (1995) 4265-4273
113. Kijima K., et al. Periaxin mutation causes early-onset but slow-progressive Charcot-Marie-Tooth disease. J Hum Genet 49 (2004) 376-379
114. Takashima H., et al. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 51 (2002) 709-715
115. Boerkoel C.F., et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 68 (2001) 325-333
116. Delague V., et al. Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am J Hum Genet 67 (2000) 236-243
117. Zhao C., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105 (2001) 587-597
118. Bomont P., et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 26 (2000) 370-374
119. Saito M., et al. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 49 (1997) 1630-1635
120. Pericak-Vance M.A., et al. Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. Neurogenetics 1 (1997) 89-93
121. Kijima K., et al. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum Genet 116 (2005) 23-27
122. Zuchner S., et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann Neurol 59 (2006) 276-281
123. Zhu D., et al. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Neurology 65 (2005) 496-497
124. Jordens I., et al. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol 11 (2001) 1680-1685
125. Cantalupo G., et al. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J 20 (2001) 683-693
126. Harrison R.E., et al. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP. Mol Cell Biol 23 (2003) 6494-6506
127. Puls I., et al. Mutant dynactin in motor neuron disease. Nat Genet 33 (2003) 455-456
128. Ge Q., Trieu E.P., and Targoff I.N. Primary structure and functional expression of human Glycyl-tRNA synthetase, an autoantigen in myositis. J Biol Chem 269 (1994) 28790-28797
129. Ionasescu V., et al. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT 2D). Hum Mol Genet 5 (1996) 1373-1375
130. Christodoulou K., et al. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum Mol Genet 4 (1995) 1629-1632
131. Sambuughin N., et al. Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie-Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7p15. J Neurol Sci 161 (1998) 23-28
132. Antonellis A., et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72 (2003) 1293-1299
133. Evgrafov O.V., et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36 (2004) 602-606
134. Kijima K., et al. Small heat shock protein 27 mutation in a Japanese patient with distal hereditary motor neuropathy. J Hum Genet 50 (2005) 473-476
135. Tang B., et al. Mutation analysis of the small heat shock protein 27 gene in Chinese patients with Charcot-Marie-Tooth disease. Arch Neurol 62 (2005) 1201-1207
136. Tang B.S., et al. Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L. Hum Genet 116 (2005) 222-224
137. Klein C.J., et al. The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology 60 (2003) 1151-1156
138. Bitoun M., et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37 (2005) 1207-1209
139. Zuchner S., et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet 37 (2005) 289-294
140. Jordanova A., et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38 (2006) 197-202
141. Stuurman N., Heins S., and Aebi U. Nuclear lamins: their structure, assembly, and interactions. J Struct Biol 122 (1998) 42-66
142. De Sandre-Giovannoli A., et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. [erratum: Am J Hum Genet 2002;70:1075]. Am J Hum Genet 70 (2002) 726-736
143. Bonne G., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21 (1999) 285-288
144. Raffaeledi Barletta M., et al. Different mutations in the LMNA gene casue atuosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 66 (2000) 1407-1412
145. Muchir A., et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 9 (2000) 1453-1459
146. Fatkin D., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. Am J Cardiol 83 (1999) 13H-18H [comment]
147. Novelli G., et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 71 (2002) 426-431
148. Shackleton S. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. 2000 [comment].
149. Stogbauer F., et al. Autosomal dominant burning feet syndrome. J Neurol Neurosurg Psychiatry 67 (1999) 78-81
150. Dawkins J.L., et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 27 (2001) 309-312
151. Bejaoui K., et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 27 (2001) 261-262
152. Snell E.E., Dimari S.J., and Brady R.N. Biosynthesis of sphingosine and dihydrosphingosine by cell-free systems from Hansenula ciferri. Chem Phys Lipids 5 (1970) 116-138
153. Medlock K.A., and Merrill Jr. A.H. Inhibition of serine palmitoyltransferase in vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by beta- chloroalanine. Biochemistry 27 (1988) 7079-7084
154. Herget T., et al. Production of ceramides causes apoptosis during early neural differentiation in vitro. J Biol Chem 275 (2000) 30344-30354
155. Schambelan M., Sebastian A., and Rector Jr. F.C. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int 19 (1981) 716-727
156. Lafreniere R.G., et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type ii through the study of Canadian genetic isolates. Am J Hum Genet 74 (2004) 1064-1073
157. Takagi M., et al. New HSN2 mutation in Japanese patient with hereditary sensory and autonomic neuropathy type 2. Neurology 66 (2006) 1251-1252
158. Riviere J.B., et al. A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese family. Ann Neurol 56 (2004) 572-575
159. Dyck P.J., and Klein C.J. Hereditary sensory and autonomic neuropathies. In: Noseworthy J.H. (Ed). Neurological therapeutics principles and practice (2003), Martin Dunitz, London 2188-2193
160. Axelrod F.B., et al. Progressive sensory loss in familial dysautonomia. Pediatrics 67 (1981) 517
161. Anderson S.L., et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet 68 (2001) 753-758
162. Low P.A., Burke W.J., and McLeod J.G. Congenital sensory neuropathy with selective loss of small myelinated fibers. Ann Neurol 3 (1978) 179
163. Mardy S., et al. Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. Am J Hum Genet 64 (1999) 1570-1579
164. Indo Y., et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 13 (1996) 485-488
165. McKusick V. Mendelian inheritance in man. Available at: http://www3.ncbi.nlm.nih.gov/Omim. 12th ed. Baltimore: Johns Hopkins University Press; 1998.
166. Alper G., and Narayanan V. Friedreich's ataxia. Pediatr Neurol 28 (2003) 335-341
167. Klein CJD, PJ. HMSN II (CMT2) and miscellaneous inherited system atrophies of nerve axon: clinical-molecular genetic correlations. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders; 2005. p. 1717-51.
168. Fink J.K. The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 60 (2003) 1045-1049
169. Klein C.J., et al. Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy. J Neurol Neurosurg Psychiatry 73 (2002) 45-50
170. Kuhlenbaumer G., et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet 37 (2005) 1044-1046
171. Klein CJW, Cunningham JM, Klein DM, et al. Mutation of SEPT9 is rare in American kindreds with hereditary brachial plexus neuropathy and not found in sporadic brachial plexus neuropathy (Parsonage-Turner). Neurology 2006;66(5 Supp):A86.
172. Thomas P. Other inherited neuropathies. In: Dyck P. (Ed). Peripheral neuropathies (1993), Saunders, Piladelphia 1194-1218
173. Klein C.J.D.P.J. Genetic testing in the peripheral neuropathies. J Peripher Nerv Syst 10 (2005) 77-84
174. Boerkoel C.F., et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 51 (2002) 190-201
175. Bergen III H.R., et al. Identification of transthyretin variants by sequential proteomic and genomic analysis. Clin Chem 50 (2004) 1544-1552
176. Rodriguez-Lebron E., and Paulson H.L. Allele-specific RNA interference for neurological disease. Gene Ther 13 (2006) 576-581
177. Park J.G., et al. Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem 14 (2006) 395-408
178. Lightstone F.C., et al. Identification of novel small molecule ligands that bind to tetanus toxin. Chem Res Toxicol 13 (2000) 356-362